Deficiency Diseases: all 158 studies

Page 2 of 2. Open to participants first (14), then studies with results posted, then the rest; newest registration first within each.

• Efficacy of Iron Bisglycinate in Treatment of Iron Deficiency Anemia in Pregnant WomenCompletedNCT03378791Phase 3
• Prevalence of Oral Manifestations of Iron Deficiency Anemia in a Sample of Egyptian PopulationCompletedNCT03365570
• Lactoferrin Versus Total Dose Infusion (TDI) For Treating Iron Deficiency Anemia in Pregnancy: Role of NursingCompletedNCT03279536Phase 1/2
• Buxue Yimu Pills for Gynecological Iron-Deficiency AnemiaStatus unknownNCT03232554Phase 2
• A Trial to Evaluate the Safety and Tolerability of a Novel Medical Food for Management of Iron Deficiency AnemiaCompletedNCT03038633Phase 1
• Transplantation of Autologous Oral Mucosal Epithelial Stem Cell Sheet for Treating Limbal Stem Cell Deficiency DiseaseStatus unknownNCT03015779Phase 1/2
• Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®)CompletedNCT03013439Phase 1
• Short Term Oral Iron Supplementation in Systolic Heart Failure Patients Suffering From Iron Deficiency AnemiaCompletedNCT02998697Phase 2/3
• Vitamin D Supplementation in WarfightersCompletedNCT02954549Not applicable
• Trial of Captafer® vs. Oral Iron Sulfate in the Treatment of Iron Deficiency Anemia in Patients With IBDStatus unknownNCT02774057Phase 4
• Efficacy Study of Intravenous Iron Preparation to Iron Deficiency AnemiaCompletedNCT02731534Phase 3
• The Effect of Iron Deficiency Anemia During PregnancyCompletedNCT02590224Phase 4
• Time to Relapse of Iron Deficiency Anaemia After Standard Treatment With The Intravenous Iron (Monofer®)CompletedNCT02546154
• Construction of a Health-related Quality of Life (HR-QOL) Questionnaire for Patients With Primary Antibody Deficiency DiseaseCompletedNCT02542228
• IV Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in TanzaniaStatus unknownNCT02541708Phase 3
• Ferrous Sulphate Supplement (V0355) in Women With Iron Deficiency AnaemiaTerminatedNCT02518568Phase 1
• Memory T-cell Infusion to Improve Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell TransplantationCompletedNCT02337595Phase 1/2
• Gastric Capsule Examination for Iron Deficiency AnaemiaCompletedNCT02282553Not applicable
• A Randomized, Double-blind, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Against PlaceboWithdrawnNCT02172001Phase 3
• Pharmacokinetics, Pharmacodynamics and Safety Study of Z-213 to Iron Deficiency AnemiaCompletedNCT02170311Phase 1
• The Purpose of the Study is to Examine Whether Iron Deficiency Anemia is Associated With Increased Production of Thrombin and Whether Correction of Anemia by Providing Iron Intravenously Causes a Significant Reduction in Production of Thrombin.CompletedNCT02129907
• Iron Supplementation Using Total Dose Infusion and Oral Routes for Treatment of Iron Deficiency Anemia in PregnancyCompletedNCT02086838Phase 4
• Comparison of Ferrous Sulfate, Polymaltose Complex and Iron-zinc in Iron Deficiency AnemiaCompletedNCT02076828Not applicable
• Treatment of Iron Deficiency Anemia With PregnancyCompletedNCT02005588Early Phase 1
• Observational Study on the Use of IV (Intravenous) Iron Therapy Among Subjects With Iron Deficiency AnemiaCompletedNCT01984554
• Time to Relapse of Iron Deficiency Anemia After Standard Treatment With a New Intravenous Iron (Monofer®)CompletedNCT01900197
• A Comparison Study of Bypassing Agent Therapy With and Without Tranexamic Acid in Haemophilia A Patients With InhibitorCompletedNCT01800435Phase 4
• Ferrous Sulphate Supplement in Women With Iron Deficiency AnaemiaCompletedNCT01757119Phase 1
• Enhancing Treatment of Iron Deficiency and Iron Deficiency Anemia With an Antioxidant, Vitamin ECompletedNCT01700426Phase 1
• Evaluate Bacteriophage as a Useful Immunogen in Patients With Primary Immune Deficiency Diseases (PIDD)Status unknownNCT01617122Not applicable
• Compassionate Use of Triheptanoin (C7) for Inherited Disorders of Energy MetabolismNo longer availableNCT01461304
• IV Iron Sucrose vs Oral FeSO4 in Treating IDA in Pediatric IBDWithdrawnNCT01438372Phase 2
• Effects of 5-Aminolevulinic Acid on Iron Deficiency AnemiaCompletedNCT01380548Not applicable
• Bovine Lactoferrin to Prevent and Cure Iron Deficiency and Iron Deficiency Anemia in Complicated PregnanciesCompletedNCT01221844Phase 4
• Effect of Consuming Food Cooked in Iron Utensils on Iron Status in Children With Iron Deficiency Anemia (IDA)CompletedNCT01115023Not applicable
• Effects of Dietary Heme/Non-heme Iron and Helicobacter Pylori (Hp) Infection on Maternal Iron-deficiency Anemia and Fetal Growth OutcomesStatus unknownNCT01071759
• The Anemia Control Program: Early InterventionCompletedNCT00998998Not applicable
• FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-CORCompletedNCT00810030Phase 3
• Efficacy and Safety Study of Iron Sucrose and Oral Iron Acetyl-transferrin HydroglycerinCompletedNCT00802139Phase 4
• Capsule Endoscopy vs Standard of Care for Obscure Intestinal BleedingCompletedNCT00694954Not applicable
• Lithium and Acetate for Canavan DiseaseWithdrawnNCT00657748Phase 2
• Iron Deficiency Anemia Can be an Indication for Treatment of Subclinical HypothyroidismCompletedNCT00535561Phase 1
• Alglucosidase Alfa Temporary Access ProgramApproved for marketingNCT00520143
• A Test of Iron Malabsorption in Patients With Iron Deficiency AnemiaCompletedNCT00399191Phase 1
• A Multicenter Study of the Efficacy of Cerezyme in Testing Skeletal Disease in Patients With Type I Gaucher Disease.CompletedNCT00365131Phase 4
• Is Helicobacter Pylori Infection a Cause or Treatment Failure of Iron Deficiency Anemia in Children in Bangladesh?CompletedNCT00284700Not applicable
• GTA-Glyceryltriacetate for Canavan DiseaseStatus unknownNCT00278707Phase 1
• Safety and Effectiveness Study of rhGAA in Patients With Advanced Late-Onset Pompe Disease Receiving Respiratory SupportCompletedNCT00268944Phase 3
• A Study of rhGAA in Patients With Late-Onset Pompe DiseaseCompletedNCT00250939Phase 2
• IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell ImmunodeficiencyCompletedNCT00228852Phase 1/2
• Iron Therapy in Colo-Rectal Neoplasm and Iron Deficiency Anemia: Intravenous Iron Sucrose Versus Oral Ferrous Sulphate.Status unknownNCT00199277Phase 4
• Relation Between Maternal Iodine Status and Prenatal Foetal Thyroid DimensionCompletedNCT00162539Not applicable
• rhGAA in Patients With Infantile-onset Glycogen Storage Disease-II (Pompe Disease)CompletedNCT00053573Phase 1/2
• A Study of the Safety and Pharmacokinetics of rhGAA in Siblings With Glycogen Storage Disease Type IICompletedNCT00051935Phase 2
• Safety and Efficacy of Recombinant Human Acid Alpha-Glucosidase in the Treatment of Classical Infantile Pompe DiseaseCompletedNCT00025896Phase 2
• Effects of Dietary Carbohydrate and Fat on HormonesCompletedNCT00016848
• Phase I Study of Adenoviral Vector Mediated Gene Transfer for Ornithine Transcarbamylase in Adults With Partial Ornithine Transcarbamylase DeficiencyTerminatedNCT00004498Phase 1
• Phase I Pilot Study of Liver-Directed Gene Therapy for Partial Ornithine Transcarbamylase DeficiencyTerminatedNCT00004386Phase 1

← Deficiency Diseases overview